{
    "clinical_study": {
        "@rank": "82180", 
        "arm_group": [
            {
                "arm_group_label": "Placebo (isotonic saline)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Endotoxin + isotonic saline. Reference for model of acute inflammatory illness"
            }, 
            {
                "arm_group_label": "Acipimox + Placebo (isotonic saline)", 
                "arm_group_type": "Experimental", 
                "description": "Endotoxin + Acipimox + Placebo (isotonic saline). Intervention: blockage of endogenous lipolysis."
            }, 
            {
                "arm_group_label": "Acipimox + free fatty acids", 
                "arm_group_type": "Experimental", 
                "description": "Endotoxin + Acipimox + free fatty acids. Intervention: free fatty acids"
            }, 
            {
                "arm_group_label": "Acipimox + 3-hydroxybutyrate", 
                "arm_group_type": "Experimental", 
                "description": "Endotoxin + Acipimox + 3-hydroxybutyrate. Intervention: 3-hydroxybutyrate"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that the investigators can detect protein-sparing effects of\n      administration of the ketone 3-hydroxybutyrate and free fatty acids during simulation of an\n      acute inflammatory disease. The investigators use the infusion of endotoxin, US standard\n      reference E.coli in healthy subjects as a model for inflammation / infection and to evaluate\n      the effect on protein metabolism using different tracers and the investigators can measure\n      the various intracellular signaling pathways of selected muscle and adipose tissue."
        }, 
        "brief_title": "Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals.", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Systemic Inflammatory Response Syndrome", 
        "condition_browse": {
            "mesh_term": "Systemic Inflammatory Response Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 < body mass index < 30 kg/m2.\n\n          -  written and orally informed consent before enrollment.\n\n        Exclusion Criteria:\n\n          -  participation in other studies using radioactive tracers or other exposure to\n             radiation (X-rays, scintigraphy etc).\n\n          -  allergy to soy products or eggs\n\n          -  diabetes, any type\n\n          -  epilepsy\n\n          -  ongoing infection\n\n          -  immune deficiency\n\n          -  cardiovascular disease\n\n          -  dysregulated hypertension\n\n          -  primary muscles disease, congenital or acquired"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752348", 
            "org_study_id": "11422796", 
            "secondary_id": "1-10-72-530-12"
        }, 
        "intervention": {
            "arm_group_label": [
                "Placebo (isotonic saline)", 
                "Acipimox + Placebo (isotonic saline)", 
                "Acipimox + free fatty acids", 
                "Acipimox + 3-hydroxybutyrate"
            ], 
            "intervention_name": "Endotoxin, US standard reference E.coli", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Acipimox"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "sepsis", 
            "cytokine release", 
            "fever"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aarhus C", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Medical Research Laboratory, Department of Internal Medicine and Endocrinology"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals; a Study on Muscle Wasting and Metabolism During Acute Inflammation and Potential Anabolic Mechanisms.", 
        "other_outcome": {
            "measure": "Other systemic metabolic effects", 
            "safety_issue": "No", 
            "time_frame": "6 hours of intervention"
        }, 
        "overall_official": {
            "affiliation": "Institute of Clinical Medicine, Aarhus University, Denmark. Department of Internal Medicin and Endocrinology, Aarhus university hospital, Aarhus, Denmark.", 
            "last_name": "Niels M\u00f8ller, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurements of protein oxidation during intervention using radioactive tracer techniques.", 
            "measure": "Protein metabolism", 
            "safety_issue": "No", 
            "time_frame": "6 hours intervention period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752348"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Measurements on biopsies from muscle and fatty tissue taken on day of study", 
            "measure": "Activated intracellular signalling pathways", 
            "safety_issue": "No", 
            "time_frame": "study day"
        }, 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}